Crf1 receptor antagonist for the treatment of adrenal hyperplasia congenital
PA94290A1Pending Publication Date: 2026-09-09NEUROCRINE BIOSCIENCES INC +1
0 Cites 0 Cited by
Patent Information
- Application Number
- PA94290
- Authority / Receiving Office
- PA · PA
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2022-12-07
- Publication Date
- 2026-09-09
Abstract
METHODS RELATED TO THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA IN A SUBJECT IN NEED ARE PROVIDED, COMPRISING THE ADMINISTRATION TO THE SUBJECT OF A COMPOUND OF FORMULA (I): OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.
Need to check novelty before this filing date? Find Prior Art